This tenuous position was illustrated here last fall in the space of a few hours and about a city block. When biologist J. Leslie Glick described his company's development of a test for Alzheimer's disease to about 50 interested business executives and scientists at a seminar, he faltered on a key question about how well the preliminary test worked. His company, Bionix Inc. of Potomac, Md., then lost its luster for these potential financial partners, who want proof as well as promise.
J. Leslie Glick, president and chief executive officer of Bionix Inc. of Potomac, Md., insists that he never really intended to start a neurospecialty company. "I essentially had decided to retire," recalls the 68-year-old biologist and biotech executive. "But there are only so many museums in Washington, and I wanted to do something that would benefit the elderly." Although a molecular and cellular biologist by training, Glick had ...
